Meeting NewsVideo

VIDEO: Thyroid ‘year in review’ covers clinical studies with impact

CHICAGO— In this video exclusive, Naifa Lamki Busaidy, MD, FACP, FACE, associate professor in the department of endocrine neoplasia and hormonal disorders at The University of Texas MD Anderson Cancer Center in Houston, discusses recent peer-reviewed research that has had an impact on medical thyroidology — from hypothyroidism to thyroid cancer.

References in order of presentation are below:

Hypothyroidism

  • Dhillon-Smith RK, et al. N Eng J Med. 2019;doi:10.1056/NEJMoa1812537.
  • Guldvog I, et al. Ann Intern Med. 2019;doi: 10.7326/M18-0284.

Hyperthyroidism

  • Azizi F, et al. Thyroid. 2019;doi: 10.1089/thy.2019.0180.

Morbidities from other therapies

  • Kitahara CM, et al. JAMA Intern Med. 2019;doi:10.1001/jamainternmed.2019.0981.
  • Okosieme OE, et al. Lancet Diabetes Endocrinol. 2019;doi: 10.1016/S2213-8587(19)30059-2.
  • Iyer PC, et al. Thyroid. 2018;doi: 10.1089/thy.2018.0116.

Thyroid cancer

  • Oh HS, et al. Thyroid. 2019;doi:10.1089/thy.2018.0609
  • Papaleontiou M, et al. Thyroid. 2019;doi:10.1089/thy.2019.0163.
  • Wallner LP, et al. J Clin Oncol. 2019;doi:10.1200/JCO.18.02228.

Disclosure: Busaidy reports she has received consultant fees from Eisai and Loxo Oncology and research funding from Novartis.

CHICAGO— In this video exclusive, Naifa Lamki Busaidy, MD, FACP, FACE, associate professor in the department of endocrine neoplasia and hormonal disorders at The University of Texas MD Anderson Cancer Center in Houston, discusses recent peer-reviewed research that has had an impact on medical thyroidology — from hypothyroidism to thyroid cancer.

References in order of presentation are below:

Hypothyroidism

  • Dhillon-Smith RK, et al. N Eng J Med. 2019;doi:10.1056/NEJMoa1812537.
  • Guldvog I, et al. Ann Intern Med. 2019;doi: 10.7326/M18-0284.

Hyperthyroidism

  • Azizi F, et al. Thyroid. 2019;doi: 10.1089/thy.2019.0180.

Morbidities from other therapies

  • Kitahara CM, et al. JAMA Intern Med. 2019;doi:10.1001/jamainternmed.2019.0981.
  • Okosieme OE, et al. Lancet Diabetes Endocrinol. 2019;doi: 10.1016/S2213-8587(19)30059-2.
  • Iyer PC, et al. Thyroid. 2018;doi: 10.1089/thy.2018.0116.

Thyroid cancer

  • Oh HS, et al. Thyroid. 2019;doi:10.1089/thy.2018.0609
  • Papaleontiou M, et al. Thyroid. 2019;doi:10.1089/thy.2019.0163.
  • Wallner LP, et al. J Clin Oncol. 2019;doi:10.1200/JCO.18.02228.

Disclosure: Busaidy reports she has received consultant fees from Eisai and Loxo Oncology and research funding from Novartis.

    See more from American Thyroid Association